With profit as the most obvious motive, psychiatry is pushing dangerous psychedelic drugs at every turn. New research studies are pushing back.
Excited reports from “studies” praise the effects of the brain-scrambling drugs. Just hop on the hokum train, grab a bottle of whatever psychedelic mixture they’re peddling this week, take a big old swig and—they swear—overnight you’ll be right as rain. And, they claim, a growing body of clinical trials say it’s so. Scads of them are currently underway on various psychedelic drugs, from the date-rape drug ketamine to psilocybin and even LSD.
But a daring and concerned group of researchers at the University of Rennes in France has gone against the money-grubbing psychiatric trend, leading a new study of existing clinical trial reports. The researchers found that psychedelics have been wildly misrepresented, inaccurate claims of study results have been improperly exaggerated and the dangers of the drugs have been seriously minimized.
